Eleven Biotherapeutics (NASDAQ: EBIO), a clinical-stage
biopharmaceutical company discovering and developing protein
therapeutics to treat diseases of the eye, today reported financial
results for the third quarter ended September 30, 2014 and recent
Q3 revenue of $228.3M, up 9% from year-ago quarter, and flat sequentially
Q3 EPS of $1.47 per diluted share, up 3% from year-ago quarter, and 4% sequentially
Q3 cash & short term investments of $808.7M
Global Headcount of 24,333 on September 30, 2014, up 6% from year-ago quarter
TROY, Mich., Oct.
PPG Industries’ (NYSE:PPG) aerospace transparencies group has been
selected by Gulfstream to supply windshields, side cockpit windows and
passenger-cabin window assemblies for the G500™ and G600™ business jets
that will provide superior performance for operators and maximum
efficiencies for Gulfstream.
McAfee, part of Intel Security, today kicked off the company’s fourth
annual Partner Summit, providing nearly 700 channel partners from around
the globe with the opportunity to engage with McAfee executives and
ICAP plc (IAP.L), a leading markets operator and provider of post trade
risk mitigation and information services, announces today that it will
hold its 22nd annual global Charity Day on Wednesday, December 3, 2014.
By Darrell Delamaide, MarketWatch
WASHINGTON (MarketWatch) -- As victorious Republicans gleefully anticipate quick congressional approval of the Keystone XL pipeline after their gains in midterm elections, plunging oil prices threaten to make the project to transport Canada's oil sands production a white elephant before it can ever be built.
By Kirsten Grind And Gregory Zuckerman
After Bill Gross abruptly quit Pacific Investment Management Co., the bond-fund giant he co-founded, in September to join a much smaller rival, the big question was how much money would follow him.
Independent. Insightful. Trusted. Morningstar provides stock market analysis; equity, mutual fund, and ETF research, ratings, and picks; portfolio tools; and option, hedge fund, IRA, 401k, and 529 plan research. Our reliable data and analysis can help both experienced enthusiasts and newcomers.